Toxicity from the recreational use of 1-benzylpiperazine

@article{Gee2008ToxicityFT,
  title={Toxicity from the recreational use of 1-benzylpiperazine},
  author={Pauline Gee and Mark Gilbert and Sandra Richardson and Grant A. Moore and Sharon Paterson and Patrick J. Graham},
  journal={Clinical Toxicology},
  year={2008},
  volume={46},
  pages={802 - 807}
}
Aim. This study describes the demographics and symptoms of patients, who presented to the Emergency Department (ED) in Christchurch, New Zealand, with toxicity from 1-benzylpiperazine (BZP)-based “party pills.” BZP use has become widespread among the 16- to 30-year age group in New Zealand. This study explores the relationship between plasma BZP level and adverse effects experienced by users. The influence of ethanol co-ingestion was also studied. Methods. From 1 April 2005 to 1 July 2007, all… 
Multiorgan failure from 1-benzylpiperazine ingestion – legal high or lethal high?
TLDR
It is suggested that BZP alone has the potential to cause serious sympathomimetic toxicity and the effects may possibly be synergistic when co-ingested.
Update on 1-benzylpiperazine (BZP) party pills
TLDR
The in vivo and in vitro studies performed in order to understand its pharmacology, toxicology and kinetics are discussed and analytical methodologies for the identification of BZP in clinical and forensic settings are addressed.
Current awareness of piperazines: pharmacology and toxicology.
TLDR
This paper reviews the current pharmacological and toxicological information for piperazine derivatives and also includes new ante-mortem and post-mortem blood data.
Determining the subjective and physiological effects of BZP combined with TFMPP in human males
TLDR
These physiological and subjective data reflect clear similarities between the effects of BZP/TFMPP and commonly known stimulants such as dexamphetamine and MDMA.
Nephrotoxicity of recreational party drugs
N‐benzylpiperazine (BZP) is the active ingredient in recreational ‘party’ pills with a stimulant, euphoric mechanism of action akin to that of 3,4‐methylenedioxymethamphetamine (MDMA or ecstasy).
Clinical pattern of poisoning among patients declared as taking novel recreational drugs.
TLDR
Preliminary results of this research show that financial problems and a history of psychiatric treatment may enhance suicidal ideation in patients after acute poisoning by psychoactive substances.
The clinical toxicology of the designer “party pills” benzylpiperazine and trifluoromethylphenylpiperazine
TLDR
The mechanisms of toxicity, toxicokinetics, clinical features, diagnosis, and management of poisoning due to BZP and TFMPP are reviewed.
An In Vitro Study of the Neurotoxic Effects of N-Benzylpiperazine: A Designer Drug of Abuse
TLDR
A novel, preliminary attempt to explain the toxicity of one of the most popular designer drug of abuse at the cellular level by following the neurotoxic effect of N-benzylpiperazine using the human cancer LN-18 cell model.
Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination.
The use of piperazine derivatives, colloquially named 'party pills', has been escalating in New Zealand and worldwide since their introduction in the 1990s. Benzylpiperazine (BZP) is often used
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand.
TLDR
The results of this study indicate that BZP can cause unpredictable and serious toxicity in some individuals, and should be carefully considered in any discussion on the legal status of piperazine-based party pills.
Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts
TLDR
It was concluded that 1-benzylpiperazine is a compound liable to abuse by an addict population, and that this type of study might be of value in predicting abuse liability of other new drugs.
A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests
TLDR
It was concluded that 1-benzylpiperazine has psychomotor stimulant activity similar to dexamphetamine and that this was most reliably detected by using a prolonged signal detection test.
A2 (N-benzylpiperazine) a new drug of abuse in Sweden.
N-Benzylpiperazine was tested in the beginning of the 1970s as a possible antidepressant drug. However, in both animal and human studies, it was shown to possess amphetamine-like properties, and any
THE RELATIONSHIP OF HYPOMAGNESEMIA AND ALKALOSIS TO ALCOHOL WITHDRAWAL SYMPTOMS
  • S. Wolfe, M. Victor
  • Medicine, Psychology
    Annals of the New York Academy of Sciences
  • 1969
TLDR
It was found that the seizures occurred between 7 and 48 hours after the withdrawal of alcohol in more than 90 percent of cases, with a peak incidence between 13 and 24 hours, which tends to discredit the notion that alcohol precipitates seizures only in those with “latent epilepsy” or a “constitutional predisposition” to seizures.
[Fatal brain edema after ingestion of ecstasy and benzylpiperazine].
TLDR
The patient deteriorated neurologically with increasing tonsillar herniation detected in a second brain CT scan, and died 57 hours after admission, of MDMA-associated severe hyponatraemia.
Metabolism of designer drugs of abuse.
TLDR
The metabolism of new designer drugs of abuse that have emerged on the black market during the last years are reviewed and papers describing identification of in vivo or in vitro human or animal metabolites and cytochrome P450 isoenzyme dependent metabolism have been considered.
Species differences in the in vitro metabolism of EGYT-475, a new antidepressant agent.
TLDR
The metabolism of N-benzyl-piperazine-picolinyl fumarate (EGYT-475), a new antidepressant agent, was studied in rat and dog liver homogenate and microsomes and the possibility of the formation of polar conjugates was also studied.
Effects of “Legal X” Piperazine Analogs on Dopamine and Serotonin Release in Rat Brain
TLDR
The hypothesis that the BZP/TFMPP combination mimics the neurochemical mechanism of MDMA, providing a basis for recreational use of these agents, is supported and the findings suggest possible drug‐drug synergism when piperazine drugs are coadministered at high doses.
...
1
2
3
...